Risk of Serious Infection Associated with Agents that Target T-Cell Activation and Interleukin-17 and Interleukin-23 Cytokines

Publication date: June 2020Source: Infectious Disease Clinics of North America, Volume 34, Issue 2Author(s): Stanford Shoor
Source: Infectious Disease Clinics of North America - Category: Infectious Diseases Source Type: research